The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 7, 2011, Pages 578-587

  Stone, Jeremy G ^a   Siedlak, Sandra L ^a   Tabaton, Massimo ^b   Hirano, Asao ^c   Castellani, Rudy J ^d   Santocanale, Corrado ^e   Perry, George ^f   Smith, Mark A ^a   Zhu, Xiongwei ^a   Lee, Hyoung Gon ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^f UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Dementia pugilistica; Neurodegeneration with brain iron accumulation type 1; Neurofibrillary tangles; Pick disease; Progressive supranuclear palsy; Retinoblastoma protein; Subacute sclerosing panencephalitis; Tau pathology

Indexed keywords

RETINOBLASTOMA PROTEIN; TAU PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL LOSS; CONTROLLED STUDY; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SUBACUTE SCLEROSING PANENCEPHALITIS; TAUOPATHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN STEM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; TAUOPATHIES; YOUNG ADULT;

EID: 79959512528     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182204414     Document Type: Article

References (60)

1. Ma D, Zhou P, Harbour JW. Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb. J Biol Chem 2003; 278:19358-66 (Pubitemid 36799331)
2. Poznic M. Retinoblastoma protein: A central processing unit. J Biosci 2009;34:305-12
3. Ohtani K. Implication of transcription factor E2F in regulation of DNA replication. Front Biosci 1999;4:D793-804
4. Ranganathan S, Scudiere S, Bowser R. Hyperphosphorylation of the reti-noblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. J Alzheimers Dis 2001;3:377-85 (Pubitemid 32843054)
5. Lundberg AS, Weinberg RA. Functional inactivation of the retinoblas-toma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998;18:753-61 (Pubitemid 28063408)
6. Mittnacht S. Control of pRB phosphorylation. Curr Opin Genet Dev 1998;8:21-27 (Pubitemid 28122136)
7. Chew YP, Ellis M, Wilkie S, et al. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F. Oncogene 1998;17:2177-86 (Pubitemid 28515371)
8. Herwig S, Strauss M. The retinoblastoma protein: A master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 1997;246: 581-601 (Pubitemid 27252898)
9. INK4A-mediated growth suppression. Mol Cell Biol 1996;16:1047-57
10. Bowser R, Smith MA. Cell cycle proteins in Alzheimer's disease: Plenty of wheels but no cycle. J Alzheimers Dis 2002;4:249-54 (Pubitemid 35006056)
11. Arendt T, Rodel L, Gartner U, et al. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 1996;7: 3047-49 (Pubitemid 26426387)
12. McShea A, Harris PL, Webster KR, et al. Abnormal expression of the cell cycle regulators p16 and CDK4 in Alzheimer's disease. Am J Pathol 1997;150:1933-39 (Pubitemid 27233067)
13. Nagy Z, Esiri MM, Cato AM, et al. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol 1997;94:6-15 (Pubitemid 27289096)
14. Nagy Z, Esiri MM, Smith AD. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (Berl) 1997;93:294-300 (Pubitemid 27104426)
15. Raina AK, Monteiro MJ, McShea A, et al. The role of cell cycle-mediated events in Alzheimer's disease. Int J Exp Pathol 1999;80:71-76 (Pubitemid 29197272)
16. McShea A, Wahl AF, Smith MA. Re-entry into the cell cycle: A mechanism for neurodegeneration in Alzheimer disease. Med Hypotheses 1999; 52:525-27 (Pubitemid 29322571)
17. Harris PL, Zhu X, Pamies C, et al. Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes. Neurobiol Aging 2000;21: 837-41
18. Zhu X, Rottkamp CA, Raina AK, et al. Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. Neurobiol Aging 2000;21: 807-13
19. Ogawa O, Lee HG, Zhu X, et al. Increased p27, an essential component of cell cycle control, in Alzheimer's disease. Aging Cell 2003;2:105-10
20. Ogawa O, Zhu X, Lee HG, et al. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: A mitotic catastrophe? Acta Neuro-pathol (Berl) 2003;105:524-28 (Pubitemid 36798850)
21. Previll LA, Crosby ME, Castellani RJ, et al. Increased expression of p130 in Alzheimer disease. Neurochem Res 2007;32:639-44 (Pubitemid 46481295)
22. Thakur A, Siedlak SL, James SL, et al. Retinoblastoma protein phos-phorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. Int J Clin Exp Pathol 2008;1:134-46
23. Bonda DJ, Evans TA, Santocanale C, et al. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging (Milano) 2009;1:382-88
24. Perry G, Castellani RJ, Hirai K, et al. Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimers Dis 1998;1:45-55
25. Miklossy J, Steele JC, Yu S, et al. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). Acta Neuropathol 2008;116:625-37
26. Perry G, Stewart D, Friedman R, et al. Filaments of Pick's bodies contain altered cytoskeletal elements. Am J Pathol 1987;127:559-68 (Pubitemid 17089817)
27. Pollock NJ, Mirra SS, Binder LI, et al. Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau. Lancet 1986;2:1211 (Pubitemid 17179052)
28. Ghatak NR, Nochlin D, Hadfield MG. Neurofibrillary pathology in progressive supranuclear palsy. Acta Neuropathol 1980;52:73-76 (Pubitemid 10011161)
29. Tabaton M, Whitehouse PJ, Perry G, et al. Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. Ann Neurol 1988;24:407-13
30. Iwatsubo T, Hasegawa M, Ihara Y. Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics. Acta Neuropathol 1994;88:129-36 (Pubitemid 24233243)
31. Yuksel D, Yilmaz D, Uyar NY, et al. Tau proteins in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis. Brain Dev 2010;32:467-71
32. Ludolph AC, Kassubek J, Landwehrmeyer BG, et al. Tauopathies with parkinsonism: Clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol 2009;16:297-309
33. Rosso SM, Kamphorst W, Ravid R, et al. Coexistent tau and amyloid pathology in hereditary frontotemporal dementia with tau mutations. Ann N Y Acad Sci 2000;920:115-19 (Pubitemid 32056559)
34. Toth C, McNeil S, Feasby T. Central nervous system injuries in sport and recreation: A systematic review. Sports Med 2005;35:685-715 (Pubitemid 41215904)
35. Bonelli RM, Cummings JL. Frontal-subcortical dementias. Neurologist 2008;14:100-7 (Pubitemid 351366942)
36. Lovestone S, McLoughlin DM. Protein aggregates and dementia: Is there a common toxicity? J Neurol Neurosurg Psychiatry 2002;72:152-61
37. Takeda A, Smith MA, Avila J, et al. In Alzheimer's disease, heme oxy-genase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem 2000;75:1234-41 (Pubitemid 30660513)
38. Brown VD, Phillips RA, Gallie BL. Cumulative effect of phosphory-lation of pRB on regulation of E2F activity. Mol Cell Biol 1999;19: 3246-56 (Pubitemid 29193786)
39. Mittnacht S, Lees JA, Desai D, et al. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J 1994;13:118-27
40. 1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 1991;65:381-93 (Pubitemid 121002048)
41. Jordan-Sciutto KL, Malaiyandi LM, Bowser R. Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J Neuro-pathol Exp Neurol 2002;61:358-67 (Pubitemid 34266787)
42. Vincent I, Jicha G, Rosado M, et al. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 1997;17:3588-98 (Pubitemid 27200586)
43. Smith MZ, Nagy Z, Esiri MM. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neurosci Lett 1999;271: 45-48 (Pubitemid 29369191)
44. Ding XL, Husseman J, Tomashevski A, et al. The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. Am J Pathol 2000;157:1983-90
45. Chuang LC, Teixeira LK, Wohlschlegel JA, et al. Phosphorylation of Mcm2 by Cdc7 promotes pre-replication complex assembly during cell-cycle re-entry. Mol Cell 2009;35:206-16
46. 1/S transition in human cancer cells. Oncogene 2007;26:21-29 (Pubitemid 46067328)
47. Perry G, Roder H, Nunomura A, et al. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 1999;10:2411-15 (Pubitemid 29367948)
48. Zhu X, Rottkamp CA, Boux H, et al. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol 2000;59:880-88
49. Zhu X, Rottkamp CA, Hartzler A, et al. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. J Neurochem 2001;79: 311-18 (Pubitemid 32988947)
50. Zhu X, Castellani RJ, Takeda A, et al. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: The 'two hit' hypothesis. Mech Ageing Dev 2001;123:39-46 (Pubitemid 32972257)
51. Zhu X, Sun Z, Lee HG, et al. Distribution, levels, and activation of MEK1 in Alzheimer's disease. J Neurochem 2003;86:136-42 (Pubitemid 36753854)
52. Zhu X, Lee HG, Perry G, et al. Alzheimer disease, the two-hit hypothesis: An update. Biochim Biophys Acta 2007;1772:494-502 (Pubitemid 46400383)
53. Zhu X, Raina AK, Perry G, et al. Alzheimer's disease: The two-hit hypothesis. Lancet Neurol 2004;3:219-26 (Pubitemid 38373660)
54. Camins A, Verdaguer E, Folch J, et al. The role of CDK5/P25 formation/inhibition in neurodegeneration. Drug News Perspect 2006;19: 453-60 (Pubitemid 46050819)
55. Gong CX, Iqbal K. Hyperphosphorylation of microtubule-associated protein tau: A promising therapeutic target for Alzheimer disease. Curr Med Chem 2008;15:2321-28
56. Lee KY, Helbing CC, Choi KS, et al. Neuronal Cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein. J Biol Chem 1997; 272:5622-26 (Pubitemid 27102388)
57. Hamdane M, Bretteville A, Sambo AV, et al. p25/Cdk5-mediated reti-noblastoma phosphorylation is an early event in neuronal cell death. J Cell Sci 2005;118:1291-98 (Pubitemid 40528698)
58. Hayashi T, Sakai K, Sasaki C, et al. Phosphorylation of retinoblastoma protein in rat brain after transient middle cerebral artery occlusion. Neuro-pathol Appl Neurobiol 2000;26:390-97 (Pubitemid 30609435)
59. Katchanov J, Harms C, Gertz K, et al. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J Neurosci 2001; 21:5045-53 (Pubitemid 32622930)
60. Lee HG, Casadesus G, Nunomura A, et al. The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 2009;174:891-97